Bioharvest Sciences (BHST) Cash from Financing Activities (2023 - 2025)

Bioharvest Sciences' Cash from Financing Activities history runs 3 years deep, the most recent figure standing at $14.9 million for Q4 2025.

• On a quarterly basis, Cash from Financing Activities rose 508.92% year-over-year to $14.9 million in Q4 2025; TTM through Dec 2025 was $30.2 million, a 345.24% increase from a year earlier, with the FY2025 full-year figure at $30.2 million, up 345.24% from the prior year.
• Cash from Financing Activities advanced to $14.9 million in Q4 2025 per BHST's latest filing, from $9.7 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $14.9 million in Q4 2025 and bottomed at -$164000.0 in Q3 2024.
• The 3-year median for Cash from Financing Activities is $2.8 million (2024), against an average of $4.5 million.
• Across the five-year window, Cash from Financing Activities slumped 113.86% in 2024 and surged 6036.59% in 2025, its largest moves.
• Year by year, Cash from Financing Activities stood at $7.0 million in 2023, then plunged by 64.99% to $2.5 million in 2024, then surged by 508.92% to $14.9 million in 2025.
• Per Business Quant, the three latest BHST Cash from Financing Activities figures stand at $14.9 million (Q4 2025), $9.7 million (Q3 2025), and $2.4 million (Q2 2025).